News on Medial

Related News

Somerset Indus Capital Partners closes Fund III at $288 Mn

EntrackrEntrackr · 2d ago
Somerset Indus Capital Partners closes Fund III at $288 Mn
Medial

Somerset Indus Capital Partners today announced the successful fundraise of its third fund, Fund III, at $288 million, exceeding its initial target of $250 million. Fund III witnessed robust participation from a diverse group of global institutional investors, including development finance institutions (DFIs), global investment firms, domestic financial institutions, insurance companies, funds of funds, family offices, and impact investors across Europe, the United States, and Southeast Asia. With Fund III, Somerset will continue to focus on addressing healthcare access gaps across India’s “missing middle,” particularly in Tier II and Tier III markets. The fund will invest in scalable healthcare businesses delivering affordable and accessible quality care across healthcare delivery, pharmaceuticals, medical devices, diagnostics, and allied sectors. Somerset typically invests between $15 million and $40 million per portfolio company. However, through co-investment syndication alongside its LP network, the firm has the flexibility to participate in significantly larger transactions in the range of $60–80 million. The additional capital will enable it to support larger and more structurally transformative opportunities across areas such as preventive care and OPD-linked insurance, healthcare financing, embedded insurance solutions, value-driven generics, India-focused MedTech innovation, and diagnostics platforms improving accessibility and standardisation beyond metro markets. Through Fund III, Somerset has already made three investments, including Cyrix Healthcare, Printmann Offset, and NU Hospitals. The firm claims that its earlier funds have delivered strong performance, with Fund I generating approximately 4.0x DPI, while Fund II is advancing toward exits, with its first realisation completed in September 2025 at approximately 4x MOIC.

A91 Partners closes $665 Mn Fund III

EntrackrEntrackr · 11m ago
A91 Partners closes $665 Mn Fund III
Medial

A91 Partners has announced the final close of its third fund at $665 million. With Fund III, A91 plans to continue backing growth-stage businesses and supporting founders with scale and strategic capital. “We started A91 in 2018 with the following beliefs - patient capital will play an important role in accelerating value creation in Indian businesses across sectors. We also believed in the opportunity to create a world-class Indian investment firm - for founders who are aiming to build large enduring businesses from India. All these beliefs have been strengthened over the last 6 years,” said A91 Partners in a Linkedin post. Founded in 2018 by former Peak XV partners Gautam Mago, Abhay Pandey, Kaushik Anand, and VT Bharadwaj, A91 Partners was created to support Indian entrepreneurs building long-term businesses. The firm focuses on investing across sectors such as consumer, healthcare, financial services, and technology. The firm said it remains committed to being a long-term partner to both founders and Limited Partners as it continues to grow its presence in the Indian private equity landscape. A91 Partners has also made investments in sectors like coffee, spices, and home appliances, including backing brands such as Atomberg. It led a $30 million Series B funding round in Blue Tokai Coffee Roasters. The firm’s portfolio includes companies like Digit Insurance, Inshorts, Sugar Cosmetics, Exotel, Healthkart, Paper Boat, and Plum, among others. Go Digit General Insurance, one of A91’s portfolio companies, went public last year. In a recent disclosure, the International Finance Corporation (IFC) said that it is considering an investment of up to $35 million in A91 Partners’ third fund, with the possibility of committing an additional $30 million for co-investment opportunities.

Download the medial app to read full posts, comements and news.